0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Codeine Narcotic Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-28G9873
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Codeine Narcotic Market Research Report 2022
BUY CHAPTERS

Global Codeine Narcotic Market Research Report 2025

Code: QYRE-Auto-28G9873
Report
February 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Codeine Narcotic Market Size

The global market for Codeine Narcotic was valued at US$ 749 million in the year 2024 and is projected to reach a revised size of US$ 1056 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Codeine Narcotic Market

Codeine Narcotic Market

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.
The Codeine Narcotic market is driven by the demand for effective pain management and the widespread use of codeine as an analgesic and antitussive medication. Codeine, a narcotic drug derived from opium, is prescribed to alleviate moderate to severe pain and suppress coughing. The prevalence of conditions causing pain, such as post-surgery recovery and chronic illnesses, contributes to market growth as healthcare professionals seek safe and accessible pain relief options. Moreover, codeine"s relatively lower potential for abuse compared to other narcotics aligns with its continued medical use. However, the market also faces challenges, including the potential for misuse and addiction due to codeine"s opioid properties, leading to regulatory controls and prescription limitations in various regions. Additionally, addressing patient education about codeine"s potential risks and benefits, and ensuring proper dosing and monitoring can pose obstacles for healthcare providers. To succeed, pharmaceutical companies must focus on responsible prescribing practices, patient education, and addressing the challenges to ensure the appropriate use of codeine while providing effective pain management solutions that prioritize patient safety.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Codeine Narcotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Codeine Narcotic.
The Codeine Narcotic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Codeine Narcotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Codeine Narcotic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Codeine Narcotic Market Report

Report Metric Details
Report Name Codeine Narcotic Market
Accounted market size in year US$ 749 million
Forecasted market size in 2031 US$ 1056 million
CAGR 5.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Single-ingredient Codeine
  • Multi-ingredient Medications
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma, Pharmaceutical Associates, Novartis, Apotex, Mylan, Aristo Pharma GmbH, Lannett Company, Laboratoire Riva
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Codeine Narcotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Codeine Narcotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Codeine Narcotic Market growing?

Ans: The Codeine Narcotic Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the Codeine Narcotic Market size in 2031?

Ans: The Codeine Narcotic Market size in 2031 will be US$ 1056 million.

Who are the main players in the Codeine Narcotic Market report?

Ans: The main players in the Codeine Narcotic Market are Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma, Pharmaceutical Associates, Novartis, Apotex, Mylan, Aristo Pharma GmbH, Lannett Company, Laboratoire Riva

What are the Application segmentation covered in the Codeine Narcotic Market report?

Ans: The Applications covered in the Codeine Narcotic Market report are Narcotic Analgesic, Antitussive, Others

What are the Type segmentation covered in the Codeine Narcotic Market report?

Ans: The Types covered in the Codeine Narcotic Market report are Single-ingredient Codeine, Multi-ingredient Medications

Recommended Reports

Pain Management Drugs

Opioid And Addiction

Analgesic Market

1 Codeine Narcotic Market Overview
1.1 Product Definition
1.2 Codeine Narcotic by Type
1.2.1 Global Codeine Narcotic Market Value Comparison by Type (2024 VS 2031)
1.2.2 Single-ingredient Codeine
1.2.3 Multi-ingredient Medications
1.3 Codeine Narcotic by Application
1.3.1 Global Codeine Narcotic Market Value by Application (2024 VS 2031)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Codeine Narcotic Market Size Estimates and Forecasts
1.4.1 Global Codeine Narcotic Revenue 2020-2031
1.4.2 Global Codeine Narcotic Sales 2020-2031
1.4.3 Global Codeine Narcotic Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Codeine Narcotic Market Competition by Manufacturers
2.1 Global Codeine Narcotic Sales Market Share by Manufacturers (2020-2025)
2.2 Global Codeine Narcotic Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Codeine Narcotic Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Codeine Narcotic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Codeine Narcotic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Codeine Narcotic, Product Type & Application
2.7 Global Key Manufacturers of Codeine Narcotic, Date of Enter into This Industry
2.8 Global Codeine Narcotic Market Competitive Situation and Trends
2.8.1 Global Codeine Narcotic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Codeine Narcotic Players Market Share by Revenue
2.8.3 Global Codeine Narcotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Codeine Narcotic Market Scenario by Region
3.1 Global Codeine Narcotic Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Codeine Narcotic Sales by Region: 2020-2031
3.2.1 Global Codeine Narcotic Sales by Region: 2020-2025
3.2.2 Global Codeine Narcotic Sales by Region: 2026-2031
3.3 Global Codeine Narcotic Revenue by Region: 2020-2031
3.3.1 Global Codeine Narcotic Revenue by Region: 2020-2025
3.3.2 Global Codeine Narcotic Revenue by Region: 2026-2031
3.4 North America Codeine Narcotic Market Facts & Figures by Country
3.4.1 North America Codeine Narcotic Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Codeine Narcotic Sales by Country (2020-2031)
3.4.3 North America Codeine Narcotic Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Codeine Narcotic Market Facts & Figures by Country
3.5.1 Europe Codeine Narcotic Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Codeine Narcotic Sales by Country (2020-2031)
3.5.3 Europe Codeine Narcotic Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Codeine Narcotic Market Facts & Figures by Region
3.6.1 Asia Pacific Codeine Narcotic Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Codeine Narcotic Sales by Region (2020-2031)
3.6.3 Asia Pacific Codeine Narcotic Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Codeine Narcotic Market Facts & Figures by Country
3.7.1 Latin America Codeine Narcotic Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Codeine Narcotic Sales by Country (2020-2031)
3.7.3 Latin America Codeine Narcotic Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Codeine Narcotic Market Facts & Figures by Country
3.8.1 Middle East and Africa Codeine Narcotic Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Codeine Narcotic Sales by Country (2020-2031)
3.8.3 Middle East and Africa Codeine Narcotic Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Codeine Narcotic Sales by Type (2020-2031)
4.1.1 Global Codeine Narcotic Sales by Type (2020-2025)
4.1.2 Global Codeine Narcotic Sales by Type (2026-2031)
4.1.3 Global Codeine Narcotic Sales Market Share by Type (2020-2031)
4.2 Global Codeine Narcotic Revenue by Type (2020-2031)
4.2.1 Global Codeine Narcotic Revenue by Type (2020-2025)
4.2.2 Global Codeine Narcotic Revenue by Type (2026-2031)
4.2.3 Global Codeine Narcotic Revenue Market Share by Type (2020-2031)
4.3 Global Codeine Narcotic Price by Type (2020-2031)
5 Segment by Application
5.1 Global Codeine Narcotic Sales by Application (2020-2031)
5.1.1 Global Codeine Narcotic Sales by Application (2020-2025)
5.1.2 Global Codeine Narcotic Sales by Application (2026-2031)
5.1.3 Global Codeine Narcotic Sales Market Share by Application (2020-2031)
5.2 Global Codeine Narcotic Revenue by Application (2020-2031)
5.2.1 Global Codeine Narcotic Revenue by Application (2020-2025)
5.2.2 Global Codeine Narcotic Revenue by Application (2026-2031)
5.2.3 Global Codeine Narcotic Revenue Market Share by Application (2020-2031)
5.3 Global Codeine Narcotic Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Taiji
6.1.1 Taiji Company Information
6.1.2 Taiji Description and Business Overview
6.1.3 Taiji Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Taiji Codeine Narcotic Product Portfolio
6.1.5 Taiji Recent Developments/Updates
6.2 Mallinckrodt
6.2.1 Mallinckrodt Company Information
6.2.2 Mallinckrodt Description and Business Overview
6.2.3 Mallinckrodt Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mallinckrodt Codeine Narcotic Product Portfolio
6.2.5 Mallinckrodt Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Company Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TEVA Codeine Narcotic Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Codeine Narcotic Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medreich
6.5.1 Medreich Company Information
6.5.2 Medreich Description and Business Overview
6.5.3 Medreich Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medreich Codeine Narcotic Product Portfolio
6.5.5 Medreich Recent Developments/Updates
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Company Information
6.6.2 Sanofi Aventis Description and Business Overview
6.6.3 Sanofi Aventis Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanofi Aventis Codeine Narcotic Product Portfolio
6.6.5 Sanofi Aventis Recent Developments/Updates
6.7 Cipla
6.7.1 Cipla Company Information
6.7.2 Cipla Description and Business Overview
6.7.3 Cipla Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Codeine Narcotic Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Company Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hikma Codeine Narcotic Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Company Information
6.9.2 Pharmaceutical Associates Description and Business Overview
6.9.3 Pharmaceutical Associates Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Pharmaceutical Associates Codeine Narcotic Product Portfolio
6.9.5 Pharmaceutical Associates Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Codeine Narcotic Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Company Information
6.11.2 Apotex Description and Business Overview
6.11.3 Apotex Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Apotex Codeine Narcotic Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Mylan
6.12.1 Mylan Company Information
6.12.2 Mylan Description and Business Overview
6.12.3 Mylan Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mylan Codeine Narcotic Product Portfolio
6.12.5 Mylan Recent Developments/Updates
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Company Information
6.13.2 Aristo Pharma GmbH Description and Business Overview
6.13.3 Aristo Pharma GmbH Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aristo Pharma GmbH Codeine Narcotic Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments/Updates
6.14 Lannett Company
6.14.1 Lannett Company Company Information
6.14.2 Lannett Company Description and Business Overview
6.14.3 Lannett Company Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Lannett Company Codeine Narcotic Product Portfolio
6.14.5 Lannett Company Recent Developments/Updates
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Company Information
6.15.2 Laboratoire Riva Description and Business Overview
6.15.3 Laboratoire Riva Codeine Narcotic Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Laboratoire Riva Codeine Narcotic Product Portfolio
6.15.5 Laboratoire Riva Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Codeine Narcotic Industry Chain Analysis
7.2 Codeine Narcotic Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Codeine Narcotic Production Mode & Process Analysis
7.4 Codeine Narcotic Sales and Marketing
7.4.1 Codeine Narcotic Sales Channels
7.4.2 Codeine Narcotic Distributors
7.5 Codeine Narcotic Customer Analysis
8 Codeine Narcotic Market Dynamics
8.1 Codeine Narcotic Industry Trends
8.2 Codeine Narcotic Market Drivers
8.3 Codeine Narcotic Market Challenges
8.4 Codeine Narcotic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Codeine Narcotic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Codeine Narcotic Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Codeine Narcotic Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Codeine Narcotic Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Codeine Narcotic Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Codeine Narcotic Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Codeine Narcotic Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Codeine Narcotic Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Codeine Narcotic, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Codeine Narcotic, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Codeine Narcotic, Product Type & Application
 Table 12. Global Key Manufacturers of Codeine Narcotic, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Codeine Narcotic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Codeine Narcotic as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Codeine Narcotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Codeine Narcotic Sales by Region (2020-2025) & (K Units)
 Table 18. Global Codeine Narcotic Sales Market Share by Region (2020-2025)
 Table 19. Global Codeine Narcotic Sales by Region (2026-2031) & (K Units)
 Table 20. Global Codeine Narcotic Sales Market Share by Region (2026-2031)
 Table 21. Global Codeine Narcotic Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Codeine Narcotic Revenue Market Share by Region (2020-2025)
 Table 23. Global Codeine Narcotic Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Codeine Narcotic Revenue Market Share by Region (2026-2031)
 Table 25. North America Codeine Narcotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Codeine Narcotic Sales by Country (2020-2025) & (K Units)
 Table 27. North America Codeine Narcotic Sales by Country (2026-2031) & (K Units)
 Table 28. North America Codeine Narcotic Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Codeine Narcotic Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Codeine Narcotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Codeine Narcotic Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Codeine Narcotic Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Codeine Narcotic Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Codeine Narcotic Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Codeine Narcotic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Codeine Narcotic Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Codeine Narcotic Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Codeine Narcotic Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Codeine Narcotic Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Codeine Narcotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Codeine Narcotic Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Codeine Narcotic Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Codeine Narcotic Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Codeine Narcotic Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Codeine Narcotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Codeine Narcotic Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Codeine Narcotic Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Codeine Narcotic Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Codeine Narcotic Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Codeine Narcotic Sales (K Units) by Type (2020-2025)
 Table 51. Global Codeine Narcotic Sales (K Units) by Type (2026-2031)
 Table 52. Global Codeine Narcotic Sales Market Share by Type (2020-2025)
 Table 53. Global Codeine Narcotic Sales Market Share by Type (2026-2031)
 Table 54. Global Codeine Narcotic Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Codeine Narcotic Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Codeine Narcotic Revenue Market Share by Type (2020-2025)
 Table 57. Global Codeine Narcotic Revenue Market Share by Type (2026-2031)
 Table 58. Global Codeine Narcotic Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Codeine Narcotic Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Codeine Narcotic Sales (K Units) by Application (2020-2025)
 Table 61. Global Codeine Narcotic Sales (K Units) by Application (2026-2031)
 Table 62. Global Codeine Narcotic Sales Market Share by Application (2020-2025)
 Table 63. Global Codeine Narcotic Sales Market Share by Application (2026-2031)
 Table 64. Global Codeine Narcotic Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Codeine Narcotic Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Codeine Narcotic Revenue Market Share by Application (2020-2025)
 Table 67. Global Codeine Narcotic Revenue Market Share by Application (2026-2031)
 Table 68. Global Codeine Narcotic Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Codeine Narcotic Price (US$/Unit) by Application (2026-2031)
 Table 70. Taiji Company Information
 Table 71. Taiji Description and Business Overview
 Table 72. Taiji Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Taiji Codeine Narcotic Product
 Table 74. Taiji Recent Developments/Updates
 Table 75. Mallinckrodt Company Information
 Table 76. Mallinckrodt Description and Business Overview
 Table 77. Mallinckrodt Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Mallinckrodt Codeine Narcotic Product
 Table 79. Mallinckrodt Recent Developments/Updates
 Table 80. TEVA Company Information
 Table 81. TEVA Description and Business Overview
 Table 82. TEVA Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. TEVA Codeine Narcotic Product
 Table 84. TEVA Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson Codeine Narcotic Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Medreich Company Information
 Table 91. Medreich Description and Business Overview
 Table 92. Medreich Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Medreich Codeine Narcotic Product
 Table 94. Medreich Recent Developments/Updates
 Table 95. Sanofi Aventis Company Information
 Table 96. Sanofi Aventis Description and Business Overview
 Table 97. Sanofi Aventis Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sanofi Aventis Codeine Narcotic Product
 Table 99. Sanofi Aventis Recent Developments/Updates
 Table 100. Cipla Company Information
 Table 101. Cipla Description and Business Overview
 Table 102. Cipla Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Cipla Codeine Narcotic Product
 Table 104. Cipla Recent Developments/Updates
 Table 105. Hikma Company Information
 Table 106. Hikma Description and Business Overview
 Table 107. Hikma Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hikma Codeine Narcotic Product
 Table 109. Hikma Recent Developments/Updates
 Table 110. Pharmaceutical Associates Company Information
 Table 111. Pharmaceutical Associates Description and Business Overview
 Table 112. Pharmaceutical Associates Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Pharmaceutical Associates Codeine Narcotic Product
 Table 114. Pharmaceutical Associates Recent Developments/Updates
 Table 115. Novartis Company Information
 Table 116. Novartis Description and Business Overview
 Table 117. Novartis Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Novartis Codeine Narcotic Product
 Table 119. Novartis Recent Developments/Updates
 Table 120. Apotex Company Information
 Table 121. Apotex Description and Business Overview
 Table 122. Apotex Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Apotex Codeine Narcotic Product
 Table 124. Apotex Recent Developments/Updates
 Table 125. Mylan Company Information
 Table 126. Mylan Description and Business Overview
 Table 127. Mylan Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Mylan Codeine Narcotic Product
 Table 129. Mylan Recent Developments/Updates
 Table 130. Aristo Pharma GmbH Company Information
 Table 131. Aristo Pharma GmbH Description and Business Overview
 Table 132. Aristo Pharma GmbH Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Aristo Pharma GmbH Codeine Narcotic Product
 Table 134. Aristo Pharma GmbH Recent Developments/Updates
 Table 135. Lannett Company Company Information
 Table 136. Lannett Company Description and Business Overview
 Table 137. Lannett Company Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Lannett Company Codeine Narcotic Product
 Table 139. Lannett Company Recent Developments/Updates
 Table 140. Laboratoire Riva Company Information
 Table 141. Laboratoire Riva Description and Business Overview
 Table 142. Laboratoire Riva Codeine Narcotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Laboratoire Riva Codeine Narcotic Product
 Table 144. Laboratoire Riva Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Codeine Narcotic Distributors List
 Table 148. Codeine Narcotic Customers List
 Table 149. Codeine Narcotic Market Trends
 Table 150. Codeine Narcotic Market Drivers
 Table 151. Codeine Narcotic Market Challenges
 Table 152. Codeine Narcotic Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Codeine Narcotic
 Figure 2. Global Codeine Narcotic Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Codeine Narcotic Market Share by Type: 2024 & 2031
 Figure 4. Single-ingredient Codeine Product Picture
 Figure 5. Multi-ingredient Medications Product Picture
 Figure 6. Global Codeine Narcotic Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Codeine Narcotic Market Share by Application: 2024 & 2031
 Figure 8. Narcotic Analgesic
 Figure 9. Antitussive
 Figure 10. Others
 Figure 11. Global Codeine Narcotic Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Codeine Narcotic Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Codeine Narcotic Sales (2020-2031) & (K Units)
 Figure 14. Global Codeine Narcotic Average Price (US$/Unit) & (2020-2031)
 Figure 15. Codeine Narcotic Report Years Considered
 Figure 16. Codeine Narcotic Sales Share by Manufacturers in 2024
 Figure 17. Global Codeine Narcotic Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Codeine Narcotic Players: Market Share by Revenue in Codeine Narcotic in 2024
 Figure 19. Codeine Narcotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Codeine Narcotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Codeine Narcotic Sales Market Share by Country (2020-2031)
 Figure 22. North America Codeine Narcotic Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Codeine Narcotic Sales Market Share by Country (2020-2031)
 Figure 26. Europe Codeine Narcotic Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Codeine Narcotic Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Codeine Narcotic Revenue Market Share by Region (2020-2031)
 Figure 34. China Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Codeine Narcotic Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Codeine Narcotic Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Codeine Narcotic Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Codeine Narcotic Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Codeine Narcotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Codeine Narcotic by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Codeine Narcotic by Type (2020-2031)
 Figure 56. Global Codeine Narcotic Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Codeine Narcotic by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Codeine Narcotic by Application (2020-2031)
 Figure 59. Global Codeine Narcotic Price (US$/Unit) by Application (2020-2031)
 Figure 60. Codeine Narcotic Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart